Van Regenmortel N, Moers L, Langer T, Roelant E, De Weerdt T, Caironi P, et al. Fluid-induced harm in the hospital: look beyond volume and start considering sodium. From physiology towards recommendations for daily practice in hospitalized adults. Ann Intensive Care. 2021;11:79.
Reintam Blaser A, Regli A, De Keulenaer B, Kimball EJ, Starkopf L, Davis WA, et al. Incidence, risk factors, and outcomes of intra-abdominal hypertension in critically ill patients—a prospective multicenter study (IROI Study). Crit Care Med. 2019;47:535–42.
Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med. 2008;34:707–13.
Malbrain MLNG, Chiumello D, Cesana BM, Reintam Blaser A, Starkopf J, Sugrue M, et al. A systematic review and individual patient data meta-analysis on intra-abdominal hypertension in critically ill patients: the wake-up project. World initiative on Abdominal Hypertension Epidemiology, a Unifying Project (WAKE-Up!). Minerva Anestesiol. 2014;80:293–306.
Wang N, Jiang L, Zhu B, Wen Y, Xi X-M. Fluid balance and mortality in critically ill patients with acute kidney injury: a multicenter prospective epidemiological study. Crit Care. 2015;19:371.
Salahuddin N, Sammani M, Hamdan A, Joseph M, Al-Nemary Y, Alquaiz R, et al. Fluid overload is an independent risk factor for acute kidney injury in critically ill patients: results of a cohort study. BMC Nephrol. 2017;18:45.
Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. National heart, lung, and blood institute acute respiratory distress syndrome network. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol. 2011;6:966–73.
Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107–15.
Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411–23.
Wang M, Zhu B, Jiang L, Wen Y, Du B, Wen Y, et al. Dose–response association between fluid overload and in-hospital mortality in critically ill patients: a multicentre prospective observational cohort study. BMJ Open. 2020;10:e039875-10.
Oh TK, Song I-A, Do S-H, Jheon S, Lim C. Association of perioperative weight-based fluid balance with 30-day mortality and acute kidney injury among patients in the surgical intensive care unit. J Anesth. 2019;33:354–63.
Sim J, Kwak JY, Jung YT. Association between postoperative fluid balance and mortality and morbidity in critically ill patients with complicated intra-abdominal infections: a retrospective study. Acute Crit Care. 2020;35:189–96.
Acheampong A, Vincent J-L. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015;19:251.
Kelm DJ, Perrin JT, Cartin-Ceba R, Gajic O, Schenck L, Kennedy CC. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock. 2015;43:68–73.
Neyra JA, Li X, Canepa-Escaro F, Adams-Huet B, Toto RD, Yee J, et al. Cumulative fluid balance and mortality in septic patients with or without acute kidney injury and chronic kidney disease. Crit Care Med. 2016;44:1891–900.
Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422–7.
Woodward CW, Lambert J, Ortiz-Soriano V, Li Y, Ruiz-Conejo M, Bissell BD, et al. Fluid overload associates with major adverse kidney events in critically ill patients with acute kidney injury requiring continuous renal replacement therapy. Crit Care Med. 2019;47:e753–60.
Berthelsen RE, Perner A, Jensen AK, Jensen J-U, Bestle MH. Fluid accumulation during acute kidney injury in the intensive care unit. Acta Anaesthesiol Scand. 2018;62:780–90.
Zhang L, Chen Z, Diao Y, Yang Y, Fu P. Associations of fluid overload with mortality and kidney recovery in patients with acute kidney injury: a systematic review and meta-analysis. J Crit Care. 2015;30:860.e7-860.e13.
Vaara ST, Korhonen A-M, Kaukonen K-M, Nisula S, Inkinen O, Hoppu S, et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 2012;16:R197.
Rosenberg AL, Dechert RE, Park PK, Bartlett RH, NIH NHLBI ARDS Network. Review of a large clinical series: association of cumulative fluid balance on outcome in acute lung injury: a retrospective review of the ARDSnet tidal volume study cohort. J Intens Care Med. 2009;24:35–46.
Wiegers EJA, Lingsma HF, Huijben JA, Cooper DJ, Citerio G, Frisvold S, et al. Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study. Lancet Neurol. 2021;20:627–38.
McCoy IE, Chertow GM, Chang TIH. Patterns of diuretic use in the intensive care unit. PLoS ONE. 2019;14:e0217911.
Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Diuretics and mortality in acute renal failure. Crit Care Med. 2004;32:1669–77.
Silversides JA, McAuley DF, Blackwood B, Fan E, Ferguson AJ, Marshall JC. Fluid management and deresuscitation practices: a survey of critical care physicians. Journal of the Intensive Care Society. 2020;21:111–8.
Wichmann S, Barbateskovic M, Lindschou J, Gluud C, Perner A, Bestle MH. Loop diuretics in adult intensive care patients with fluid overload: a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Acta Anaesthesiol Scand. 2020;64:1327–34.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. www.training.cochrane.org/handbook. Accessed 3 May 2021.
Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Metodol. 2014;14:120.
Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE Handbook. October 2013. https://gdt.gradepro.org/app/handbook/handbook.html. Accessed 3 May 2021.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009. https://doi.org/10.1136/bmj.b2700.
Committee for Human Medicinal Products (2016). Guideline for good clinical practice E6(R2). https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e-6-r2-guideline-good-clinical-practice-step-5_en.pdf. Accessed 8 Apr 2021.
Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. https://www.covidence.org/. Accessed 25 May 2020.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019. https://doi.org/10.1136/bmj.l4898.
Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443–57.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Review Manager 5 (RevMan 5). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman/revman-5-download. Accessed 11 Mar 2021
Berthelsen RE, Perner A, Jensen AK, Rasmussen BS, Jensen JU, Wiis J, et al. Forced fluid removal in intensive care patients with acute kidney injury: the randomised FFAKI feasibility trial. Acta Anaesthesiol Scand. 2018;62:936–44.
Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Metodol. 2009;9:86.
Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61:763–9.
Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38:287–98.
Higgins JPT, Whitehead A, Simmonds M. Sequential methods for random-effects meta-analysis. Stat Med. 2011;30:903–21.
Imberger G, Gluud C, Boylan J, Wetterslev J. Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection. Anesth Analg. 2015;121:1611–22.
Mascha EJ. Alpha, Beta, Meta: guidelines for assessing power and type I error in meta-analyses. Anesth Analg. 2015;121:1430–3.
Pogue JM, Yusuf S. Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials. 1997;18:580–93.
Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JPA, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38:276–86.
Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61:64–75.
Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA), Copenhagen Trial Unit 2011. https://ctu.dk/wp-content/uploads/2021/03/2017-10-10-TSA-Manual-ENG_ER.pdf. Accessed 16 Jun 2021.
Kulinskaya E, Wood J. Trial sequential methods for meta-analysis. Res Synth Methods. 2014;5:212–20.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
Murad MH, Mustafa RA, Schünemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22:85–7.
Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126–35.
Bagshaw SM, Gibney RTN, Kruger P, Hassan I, McAlister FA, Bellomo R. The effect of low-dose furosemide in critically ill patients with early acute kidney injury: a pilot randomized blinded controlled trial (the SPARK study). J Crit Care. 2017;42:138–46.
Brown AJ, Cutuli SL, Eastwood GM, Bitker L, Marsh P, Bellomo R. A pilot randomised controlled trial evaluating the pharmacodynamic effects of furosemide versus acetazolamide in critically ill patients. Crit Care. 2019;21(4):258–64.
Cinotti R, Lascarrou J-B, Azais M-A, Colin G, Quenot J-P, Mahé P-J, et al. Diuretics decrease fluid balance in patients on invasive mechanical ventilation: the randomized-controlled single blind. IRIHS Study Crit Care. 2021;25:98.
Cardoso JN, Ochiai ME, Oliveira MT, Reis CM, Curiati M, Vieira KR, et al. Diuretic titration based on weight change in decompensated congestive heart failure: a randomized trial. Int J Cardiol. 2013;168:3020–1.
Hamishehkar H, Fattahi V, Mesgari M. The effect of furosemide on the level of neutrophil gelatinase-associated lipocalin in critically hospitalized patients with acute kidney injury. Indian J Crit Care Med. 2017;21:442–7.
Sanchez M, Alvarez M, Velo M, Trascasa M, Pintado C, Marian C, et al. A randomized, controlled trial (RCT) of the effect of torsemide (TOR) and low-dose dopamine (DA) on renal function in critically ill septic oliguric patients (SOP). J Am Soc Nephrol. 2003;14:44A.
Wappler F, Rödiger W. Wirkungsvergleich der schleifendiuretika furosemid und piretanid bei kardiochirurgischen intensivpatienten. Intensiv und Notfallbehandlung. 1991;16:138–43.
Han J, Li N, Wang Y. Ethacrynic acid vs. furosemide in patients with fluid overload associated with cardiac intensive care. IntJ Pharmacol. 2018;15:129–36.
Ng TMH, Grazette LP, Fong MW, Yoon AJ, Lou M, Kuo A, et al. Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF). ESC Heart Failure. 2020;7:1927–34.
NCT01072071 The influence of furosemide on fluid balance and intra-abdominal pressure in critically ill patients. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01072071
NCT02765009 Effects of Fluid Balance Control in Critically Ill Patients (POINCARE). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02765009.
NCT03512392 Role of active deresuscitation after resuscitation-2 (RADAR-2). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03512392
NCT04180397 Controlled fluid removal in critical ill patients with fluid overload in the intensive care unit (GODIF). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04180397
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
Messmer AS, Zingg C, Müller M, Gerber JL, Schefold JC, Pfortmueller CA. Fluid overload and mortality in adult critical care patients—a systematic review and meta-analysis of observational studies*. Crit Care Med. 2020;48:1862–70.
Malbrain MLNG, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anestezjol Intens Ter. 2014;46:361–80.
Silversides JA, Major E, Ferguson AJ, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43:155–70.
Ng KT, Velayit A, Khoo DKY, Mohd Ismail A, Mansor M. Continuous infusion versus intermittent bolus injection of furosemide in critically ill patients: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2018;32:2303–10.
Bandak G, Sakhuja A, Andrijasevic NM, Gunderson TM, Gajic O, Kashani K. Use of diuretics in shock: Temporal trends and clinical impacts in a propensity-matched cohort study. PLoS ONE. 2020;15: e0228274.
Shen Y, Zhang W, Shen Y. Early diuretic use and mortality in critically ill patients with vasopressor support: a propensity score-matching analysis. Crit Care. 2019;23:968.
Shahn Z, Lehman LWH, Mark RG, Talmor D, Bose S. Delaying initiation of diuretics in critically ill patients with recent vasopressor use and high positive fluid balance. Br J Anaesth. 2021;127:569–76.
Alaskar MA, Brown JD, Voils SA, Vouri SM. Loop diuretic use following fluid resuscitation in the critically ill. Am J Health Syst Pharm. 2022;79:165–72.
Mitchell KH, Carlbom D, Caldwell E, Leary PJ, Himmelfarb J, Hough CL. Volume overload: prevalence, risk factors, and functional outcome in survivors of septic shock. Ann Am Thorac Soc. 2015;12:1837–44.
Silversides JA, Perner A, Malbrain MLNG. Liberal versus restrictive fluid therapy in critically ill patients. Intensive Care Med. 2019;45:1440–2.
Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care. 2008;12:R162.
Oude Lansink-Hartgring A, Hessels L, Weigel J, de Smet AMGA, Gommers D, Panday PVN, et al. Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Ann Intensive Care. 2016;6:22.
Côté J-M, Bouchard J, Murray PT, Beaubien-Souligny W. Diuretic strategies in patients with resistance to loop-diuretics in the intensive care unit: a retrospective study from the MIMIC-III database. J Crit Care. 2021;65:282–91.
Zhang R, Chen H, Gao Z, Liang M, Qiu H, Yang Y, et al. The effect of loop diuretics on 28-day mortality in patients with acute respiratory distress syndrome. Front Med (Lausanne). 2021;8: 740675.